MT2 Peptide 30mg (R&D Only)

MT2 Peptide 30mg (Melanotan 2)

MT2 Peptide 30mg, commonly referred to as Melanotan 2 or Melanotan II, is a synthetic analog of alpha melanocyte stimulating hormone (α-MSH), a naturally occurring neuropeptide produced in the pituitary gland. Originally developed at the University of Arizona in the 1980s, this cyclic heptapeptide was specifically engineered to investigate melanogenesis pathways and photoprotection mechanisms in controlled laboratory settings. Today, MT2 Peptide remains one of the most extensively studied synthetic melanotropic peptide compounds in contemporary preclinical research, attracting significant attention across dermatology, neurobiology, and metabolic science.

Its unique cyclic lactam structure, formed through carbodiimide mediated cyclization, enhances both molecular stability and receptor binding affinity compared to linear peptide sequences. This makes MT2 a particularly valuable research compound for scientists studying the complex signalling architecture of the melanocortin system.

Mechanism of action: How MT2 works at the receptor level

The human melanocortin system consists of five distinct receptor subtypes that regulate a wide range of physiological processes, from pigment production and inflammatory response to sexual behaviour and metabolic function. MT2 Peptide interacts selectively with three of these receptor subtypes:

By acting as a potent agonist at these receptor sites, MT2 fulfils similar physiological functions to naturally occurring α-MSH but with considerably greater potency due to its enhanced structural stability and optimised binding characteristics.

Key research applications

• Melanogenesis and pigmentation research

One of the most well documented areas of MT2 Peptide research is its role in melanogenesis, the biological process by which melanocytes produce melanin. Studies confirm that Melanotan 2 promotes eumelanin synthesis, with preclinical evidence suggesting this contributes to photoprotection mechanisms against UV exposure. Research published in dermatological literature has explored its potential relevance to conditions such as vitiligo and photosensitivity disorders, making MT2 30mg an indispensable tool in pigmentation biology studies.

• Metabolic and appetite pathway studies

Through its interaction with MC3R and MC4R receptors, MT2 has been studied in relation to appetite suppression, energy balance, and lean body composition in animal models. Preclinical data indicates a measurable reduction in body fat alongside increases in lean muscle tissue, positioning Melanotan 2 as a valuable compound for researchers investigating metabolic regulation and melanocortin driven energy pathways.

• Neurobiological and behavioural signalling

MT2 Peptide 30mg has attracted growing interest in neurobiological research, particularly around behavioural signalling linked to melanocortin systems. Clinical trial data has documented measurable improvements in sexual function outcomes in both male and female subjects, providing researchers with a powerful pharmacological tool for studying the neural architecture of melanocortin mediated behaviour and downstream neuro-signalling cascades.

Peptide specifications

Why choose MT2 Peptide for your research?

Researchers and laboratory professionals choose MT2 Peptide 30mg for several compelling reasons. Its well characterised receptor binding profile makes it a precise and reproducible tool for studying melanocortin mediated pathways across multiple research disciplines. The 30mg vial size provides a generous research quantity suitable for extended study protocols, while the lyophilised powder format ensures maximum stability and extended shelf life under correct storage conditions.

Furthermore, the compound’s broad receptor activity across MC1R, MC3R, and MC4R means that a single research grade peptide can support investigations spanning dermatological, metabolic, and neurobiological domains simultaneously, offering exceptional versatility and research value per vial.